Archangels - Making The Future

Privacy Policy

STATEMENT OF INTENT

Our Privacy Policy explains how and why we collect personal information about you. We are committed to responsible management of personal information in accordance with the Data Protection Act 1998 and the Privacy and Electronic Communications (EC Directive) Regulations 2003.

COLLECTION OF PERSONAL INFORMATION

In order to receive certain information and to use certain services on this site you may be asked to provide personal information about yourself such as your name, address and email address. When you provide this information to us you consent to our use of that information in accordance with the terms of this Privacy Policy. This information will be used to provide you with the services that you have requested and to provide you with news and information about our services and those of our investee companies. If you no longer want to receive such information just let us know by email and we will stop sending it.

STORAGE OF PERSONAL INFORMATION

We will keep your personal information for as long as we need it to provide our services to you. We will try to keep personal information which we hold about you up to date, but if you think that we are holding information which is inaccurate or you are otherwise unhappy about our use of your personal information then please send us an email to let us know.

SHARING INFORMATION

We will not sell the personal information that we collect from you. We use the personal information which we collect from you to help us provide our services to you. Some data processing in relation to this site may be carried out for us by a third party and in some cases that may mean that the third party will receive your personal information. Apart from this we will not share or transfer any personal information with any other third party unless we are required to do so by law.

COOKIES

Some websites use "cookies" which are text only strings of information that the website you are visiting transfers to the cookie file of the browser on your computer. Their purpose is to identify users and to enhance the user's experience by customising web pages. A cookie will usually contain the name of the domain from which the cookie has come, an expiry date for the cookie, and a value, which is usually a random generated unique number.

Use of cookies on our site: This site does not currently use cookies. For more information about how to manage cookies visit http://www.allaboutcookies.org/

IP ADDRESS

This site logs your Internet Protocol (IP) address. All computers that are linked to the Internet have an IP address. An IP address does not provide identifiable personal information.

ACCESS

You are entitled under the Data Protection Act 1998 to a copy of the personal information that we hold about you if you apply to us in writing. We may make a small charge for dealing with any such request.

LINKS

This site provides links to other websites. Our Privacy Policy applies only to this site and we are not responsible for the privacy practices of third party sites.

Latest News

Cable gets to grips with Great British design

25 Jun 2014
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.

MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer

23 Jun 2014
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.

Touch Bionics founder receives Queen’s Honour

16 Jun 2014
David Gow named Commander of the Order of the British Empire Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.

Touch Bionics introduces new control method for bionic hand

14 May 2014
Livingston, Scotland – May 14, 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, has announced the introduction of the latest enhancements to the i-limb™ ultra revolution at the OTWorld 2014 International Congress taking place in Leipzig, Germany.

Technology Strategy Board Biomedical Catalyst Award to Drive Development of Novel System to Assess and Manage Tooth Decay (Dental Caries)

09 May 2014
Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that it has received a prestigious Biomedical Catalyst award co-funding a £0.5m development programme and raised a further £0.8m in equity funding from existing investors Archangel Informal Investment and the Scottish Investment Bank, the investment arm of Scottish Enterprise.